Clinical Trial: WAKE FOREST WF2304-A172401

WAKE FOREST WF2304-A172401

Status: New, Open

Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

Eligible for screening study DCP 001

Regulatory requirments have been complete by the MCC administrative office.

Credit accrual to Wake Forest.